Studds Accessories Q2 Profit Drops 27% Despite 18% Revenue Growth

CONSUMER-PRODUCTS
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Studds Accessories Q2 Profit Drops 27% Despite 18% Revenue Growth

Studds Accessories reported a double-digit rise in revenue to Rs 1,824.64 million for the September quarter, but net profit fell by 27.1% to Rs 155.02 million. Rising material costs weighed on margins. Additionally, the company approved a new ESOP scheme granting 130,000 options to employees at Rs 334.90 per share.

Studds Accessories Q2 Earnings Report

Standalone Net Profit: Rs 155.02 million (-27.1% YoY)
Standalone Revenue: Rs 1,824.64 million (+18.3% YoY)

Reader Takeaway: Strong revenue growth shows market demand, but rising operational costs are currently compressing bottom-line profitability significantly.

What just happened

Studds Accessories released its financial results for the quarter ended September 30, 2026. While the company achieved an 18.3% increase in standalone revenue from operations, profitability declined sharply. Net profit fell to Rs 155.02 million from Rs 212.65 million in the same quarter last year. Consolidated figures mirrored this trend, with net profit declining 28.5% to Rs 147.42 million.

Why this matters

The topline growth indicates that Studds is successfully scaling its business, yet the margin pressure suggests challenges in managing rising material and operational expenses. Investors should be cautious of how these inflationary pressures on raw materials will influence future earnings.

Corporate Developments

The company launched the 'Studds ESOP Scheme 2026' and approved a grant of 130,000 options for eligible employees. The exercise price is fixed at Rs 334.90, reflecting a 15% discount against the October 30, 2026, closing price of Rs 394.00.

Subsidiary Performance

  • SMK Helmets Europe SRL: The recently incorporated Italian subsidiary reported a net loss of Rs 9.71 million for its first reported quarter.
  • Bikerz US Inc.: This subsidiary received a capital infusion of Rs 9.48 million and posted a net profit of Rs 4.89 million.

Risks to watch

Investors should monitor the sustainability of current material costs and the ability of the management to turn the newly formed European subsidiary profitable. The primary risk remains the potential for continued margin compression if raw material prices remain elevated.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.